S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Are We in a Bear Market? Here are the Signs
2 Dollar Stores Taking Different Paths to Profitability
S&P 500 Valuations Hit New Highs: Anticipating a Market Pullback?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Are We in a Bear Market? Here are the Signs
2 Dollar Stores Taking Different Paths to Profitability
S&P 500 Valuations Hit New Highs: Anticipating a Market Pullback?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Are We in a Bear Market? Here are the Signs
2 Dollar Stores Taking Different Paths to Profitability
S&P 500 Valuations Hit New Highs: Anticipating a Market Pullback?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Are We in a Bear Market? Here are the Signs
2 Dollar Stores Taking Different Paths to Profitability
S&P 500 Valuations Hit New Highs: Anticipating a Market Pullback?
NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

$2.42
-0.06 (-2.42%)
(As of 03/18/2024 ET)
Today's Range
$2.30
$2.48
50-Day Range
$2.20
$2.61
52-Week Range
$0.85
$3.00
Volume
129,958 shs
Average Volume
95,773 shs
Market Capitalization
$461.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.80

Aveanna Healthcare MarketRank™ Stock Analysis

Analyst Rating
Strong Sell
1.40 Rating Score
Upside/​Downside
25.6% Downside
$1.80 Price Target
Short Interest
Bearish
2.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.55mentions of Aveanna Healthcare in the last 14 days
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.13) to ($0.07) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.16 out of 5 stars

Medical Sector

938th out of 947 stocks

Home Health Care Services Industry

8th out of 8 stocks

AVAH stock logo

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

AVAH Stock Price History

AVAH Stock News Headlines

8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)
THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here:
Q4 2023 Aveanna Healthcare Holdings Inc Earnings Call
Make This $3 Trade the Instant the Opening Bell Rings
Since the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…
Aveanna Healthcare Promotes Matt Buckhalter To CFO
RBC Capital Keeps Their Hold Rating on Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare Holdings Inc AVAH
Q3 2023 Aveanna Healthcare Holdings Inc Earnings Call
See More Headlines
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2023
Today
3/19/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Current Symbol
NASDAQ:AVAH
Fax
N/A
Employees
3,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.80
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
-42.1%
Consensus Rating
Strong Sell
Rating Score (0-4)
1.40
Research Coverage
6 Analysts

Profitability

Net Income
$-662,030,000.00
Pretax Margin
-18.56%

Debt

Sales & Book Value

Annual Sales
$1.90 billion
Cash Flow
$3.78 per share
Book Value
($0.03) per share

Miscellaneous

Free Float
177,572,000
Market Cap
$461.57 million
Optionable
Optionable
Beta
2.03
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Rodney D. Windley (Age 76)
    Executive Chairman
    Comp: $2.28M
  • Mr. Jeffrey S. Shaner (Age 51)
    CEO & Director
    Comp: $551.42k
  • Mr. Shannon L. Drake (Age 48)
    Chief Legal Officer & Secretary
    Comp: $401.32k
  • Mr. Matthew Buckhalter
    CFO & Principal Financial Officer
  • Ms. Debbie Stewart
    Senior VP & Principal Accounting Officer
  • Mr. Ed Reisz (Age 65)
    Chief Administrative Officer
  • Mr. Patrick A. Cunningham (Age 68)
    Chief Compliance Officer
  • Ms. Korey Hinz
    President of Medical Solutions
  • Ms. Kristy Rohwedder
    President of Private Duty Nursing
  • Mr. Shane Brinkerhoff
    President of Home Health & Hospice

AVAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Aveanna Healthcare stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" AVAH shares.
View AVAH analyst ratings
or view top-rated stocks.

What is Aveanna Healthcare's stock price target for 2024?

6 equities research analysts have issued twelve-month target prices for Aveanna Healthcare's shares. Their AVAH share price targets range from $1.00 to $3.00. On average, they anticipate the company's stock price to reach $1.80 in the next year. This suggests that the stock has a possible downside of 25.6%.
View analysts price targets for AVAH
or view top-rated stocks among Wall Street analysts.

How have AVAH shares performed in 2024?

Aveanna Healthcare's stock was trading at $2.68 at the beginning of the year. Since then, AVAH stock has decreased by 9.7% and is now trading at $2.42.
View the best growth stocks for 2024 here
.

Are investors shorting Aveanna Healthcare?

Aveanna Healthcare saw a increase in short interest in February. As of February 29th, there was short interest totaling 1,370,000 shares, an increase of 7.0% from the February 14th total of 1,280,000 shares. Based on an average daily volume of 100,300 shares, the short-interest ratio is presently 13.7 days. Currently, 2.6% of the shares of the company are sold short.
View Aveanna Healthcare's Short Interest
.

When is Aveanna Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AVAH earnings forecast
.

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its quarterly earnings data on Thursday, August, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. The company earned $471.95 million during the quarter, compared to analyst estimates of $453.19 million. Aveanna Healthcare had a negative trailing twelve-month return on equity of 70.08% and a negative net margin of 7.10%. During the same quarter in the prior year, the company earned $0.03 EPS.

What guidance has Aveanna Healthcare issued on next quarter's earnings?

Aveanna Healthcare updated its FY 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion.

When did Aveanna Healthcare IPO?

(AVAH) raised $478 million in an IPO on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Who are Aveanna Healthcare's major shareholders?

Aveanna Healthcare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Nut Tree Capital Management LP (6.49%), King Street Capital Management L.P. (3.36%), Vanguard Group Inc. (1.32%), Vanguard Group Inc. (1.32%), Putnam Investments LLC (0.53%) and Northern Trust Corp (0.22%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers, Tony Strange and Victor F Ganzi.
View institutional ownership trends
.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVAH) was last updated on 3/19/2024 by MarketBeat.com Staff

From Our Partners